SingKang: Can Singing Kangaroo Improve Outcome of Preterm Infants

Sponsor
University of Helsinki (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03795454
Collaborator
Helsinki University Central Hospital (Other), Karolinska University Hospital (Other)
140
2
115.9

Study Details

Study Description

Brief Summary

To assess whether a musical intervention (maternal/paternal singing) during the skin-to-skin sessions (Kangaroo care) would improve the language development of the preterm infant. Infants will be randomized to singing or silence during the Kangaroo care from the age corresponding to 30th gestational week until term age (40 gestational weeks).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Singing
N/A

Detailed Description

The outcomes are:

a 2- (3-)year neurodevelopmental follow up

  • Bayley Scales of Infant and Toddler Development, Third Edition (in Finnish in Finland and in Swedish in Sweden)

At the age corresponding to term (40 gestational weeks)

  • Auditory event related potentials (AERPs) in electroencephalography (EEG), in Helsinki cohort

  • Auditory event related magnetic fields in magnetoencephalgraphy (MEG) in Karolinska cohort

  • Parental stress with The State Trait Anxiety Inventory (STAI)

Study Design

Study Type:
Interventional
Actual Enrollment :
140 participants
Allocation:
Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
In Helsinki, block randomization, one intervention at the time in the hospital. In Stockholm, both groups simultaneously cared in the hospitalIn Helsinki, block randomization, one intervention at the time in the hospital. In Stockholm, both groups simultaneously cared in the hospital
Masking:
Single (Outcomes Assessor)
Masking Description:
Assessors do not know the intervention that took place before outcome assessed
Primary Purpose:
Supportive Care
Official Title:
Singing Kangaroos - Infant Care With Combined Auditory Intervention and Kangaroo Care
Actual Study Start Date :
May 3, 2013
Actual Primary Completion Date :
May 31, 2018
Anticipated Study Completion Date :
Dec 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Singing Kangaroo

The parent is singing during the skin-to -skin sessions Musical therapeutist gives the instructions

Behavioral: Singing
Infant-directed singing and singing of self-invented songs, especially songs emerging from the interaction with the infant, are especially encouraged. The families will receive audio material of children's songs, lullabies, and lyrics of the lullabies to support them if they feel unable to accomplish the task otherwise.

No Intervention: Silent Kangaroo

The parent is silent during the skin-to -skin sessions Musical therapeutist gives the instructions

Outcome Measures

Primary Outcome Measures

  1. Auditory cortical responses [Age corresponding to term, ie 40 gestational weeks]

    Auditory Event-Related Potentials (AERPs) at full-term age will be recorded with multi-feature paradigm (MFP), in which the mismatch negativity (MMN) to 5 speech-related auditory features can be recorded in a short time period.

  2. Parental anxiety [3 months age]

    Parents' state anxiety is measured using the STAI (State-Trait Anxiety Inventory, Spielberger, 1983) with 20 self-descriptive statements once per week until the infant leaves the hospital and once in two weeks until the infant reaches the corrected age of 3 months,

Secondary Outcome Measures

  1. Neurocognitive development, language development [2 year of age]

    "Bayley III" :- Bayley Scales of Infant and Toddler Develoment, Third Edition (in Finnish in Finland and in Swedish in Sweden) - The following scales will be used: Cognitive, Language, Motor, Language scale includes Expressive Language and Receptive Language Motor scale includes Fine Motorics and Gross Motorics All scale ranges will be included (i.e., minimum and maximum scores) required to interpret any values. For example, if the *total* score is reported, the *total* range should be provided. If *subscale* scores are reported, the range for each *subscale* should be provided.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • preterm infants at 30th gestational week capable of being in Kangaroo care
Exclusion Criteria:
  • intensive care preventing Kangaroo care

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Helsinki
  • Helsinki University Central Hospital
  • Karolinska University Hospital

Investigators

  • Principal Investigator: Kaija Mikkola, M.D. PhD, Helsinki University Central Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Vineta Fellman, professor, University of Helsinki
ClinicalTrials.gov Identifier:
NCT03795454
Other Study ID Numbers:
  • IRB00003181SK
First Posted:
Jan 7, 2019
Last Update Posted:
May 27, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Vineta Fellman, professor, University of Helsinki
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 27, 2022